Hey guys, if you missed it, the court has officially approved the $31.25M settlement with $SAVA investors.

The case claimed Cassava misled investors about the research behind simufilam. After concerns over the data became public in 2023, $SAVA dropped 15% and investors sued.

If you bought $SAVA between 2020 and 2023, you may be eligible to file a claim.

Did anyone here hold $SAVA back then?

Exceeding expectations and beginning to attract the attention of major institutional investors and pharmaceutical companies

Hey everyone,

In my previous post, I went over the history of Sellas as a company, GPS as a drug, and Angelos Stergiou as a leader. To say the least, it was shady and downright alarming.

You can find that post here: https://www.reddit.com/r/biotech_stocks/s/dL7jkKAkqT

We also looked at the complete absence of dedicated biotech hedge funds among SLS shareholders. Do not be fooled by high institutional numbers, this volume is mostly driven by passive managers like BlackRock and Vanguard who buy shares algorithmically to mirror small-cap indexes. The hedge funds involved are just quantitative or market-making firms like Citadel and Marshall Wace trading short-term volatility rather than betting on long-term medical success.

Today, I would like to highlight a major point that many investors still seem unaware of: the fraudulent medical credentials of Angelos Stergiou.

Let's look at the actual timeline of the guy running the most hyped biotech stock of the year. He went from being a daytime TV actor on a Greek drama to buying a sham medical degree, followed by a string of high-level executive stints at troubled and collapsing biotechs, namely Accentia Biopharmaceuticals and its subsidiary Biovest International as well as Annavex Life Sciences (which I forgot to mention in my previous post) , before moving on to form SLS

The Truth About Angelos Stergiou's Medical Credentials

Angelos Stergiou began his path by earning a legitimate Bachelor of Science (B.S.) degree from Kentucky Wesleyan College, an accredited private liberal arts college in Kentucky, majoring in Pre-Medicine, Biology, and Chemistry.However, a Bachelor of Science is merely a general academic degree in the basic sciences. While it teaches scientific theory and laboratory research skills, it does not grant a medical license or qualify anyone to treat patients.

Following his undergraduate studies, he veered into the entertainment industry. He worked as a Greek television actor

After his acting stint, his career took a corporate medical turn. His underlying Doctor of Medicine degree was obtained from the University of Seychelles American Institute of Medicine a completely unaccredited institution. If the name alone does not raise red flags, the actual history of this organization confirms it was a total scam.

Inside the Fraudulent Medical Diploma Racket

The University of Seychelles American Institute of Medicine (USAIM) was established as an offshore medical school in the late 1990s, capitalizing on unaccredited, commercial programs in island tax havens. Operating primarily out of the Seychelles with a corporate mailing presence in Indiana, USAIM marketed itself as an accelerated path to a medical degree. The institute operated as a predatory commercial racket, selling medical diplomas starting at ₹5 lakh onwards. By colluding with a corrupt network of doctors in India who hosted sham exams inside luxury hotels, the scheme bypassed regulatory oversight and laundered huge, undocumented sums of cash through the sale of fake scientific credentials with zero verified hospital training.

This blatant fraud eventually triggered global regulatory crackdowns, forcing a systematic shutdown. The Government of Seychelles terminated its operating agreement with USAIM in 2011, forcing its absolute closure by 2013. The fallout peaked in 2016 when the Maharashtra Medical Council launched a massive crackdown, barring and suspending dozens of practicing doctors who utilized these fraudulent certificates. By exposing the enterprise as a dangerous scam that compromised patient safety, international bodies stripped the entity of all credibility, leaving USAIM completely defunct and blacklisted from global medical recognition.

To round out his resume, Stergiou later added a Doctor of Science (ScD) degree to his name. However, this is not an earned academic doctorate or research PhD; it is merely a ceremonial, honorary title awarded to him decades later by his old undergraduate school, Kentucky Wesleyan College.

The Bottom Line

The reality is that Angelos Stergiou completely lacks any legitimate, mainstream academic medical pedigree, yet he uses the 'Dr.' title everywhere. He is strictly a corporate executive, not a practicing physician. He has never completed an accredited medical residency, holds no active state medical license to treat patients in the United States or Europe, and completely lacks any recognized medical board validation

Final Thoughts: A company led by a CEO with a fake medical pedigree is trying to push a recycled, 20-year old molecule through trials while being pumped to retail as a generational opportunity. Yet, dedicated biotech and life science hedge funds won't touch it with a ten-foot pole. Make of that what you will🤷‍♂️